Extracorporeal Immunomodulation Treatment and Clinical Outcomes in ICU COVID-19 Patients

To evaluate safety and clinical outcomes of extracorporeal immunomodulation treatment with a selective cytopheretic device (SCD) in COVID-19 ICU patients with multiple organ failure. DESIGN: Two-center, prospective, single-arm treatment clinical trial. SETTING: ICUs at two academic medical centers b...

Descripción completa

Detalles Bibliográficos
Autores principales: Yessayan, Lenar T., Neyra, Javier A., Westover, Angela J., Szamosfalvi, Balazs, Humes, H. David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Original Clinical Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126516/
https://www.ncbi.nlm.nih.gov/pubmed/35620768
http://dx.doi.org/10.1097/CCE.0000000000000694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126516/
https://www.ncbi.nlm.nih.gov/pubmed/35620768
http://dx.doi.org/10.1097/CCE.0000000000000694

Ejemplares similares